Lloyd A. Rowland, General Counsel at CytomX Therapeutics, Inc. (CTMX), sold 10,203 shares at $0.60 ($6K) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Open-market sale of $6k CTMX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2023-12-22 | $6K | — | Filing → |
| CTMX | SELL | 2023-09-22 | $7K | — | Filing → |
| CTMX | SELL | 2023-03-20 | $4K | — | Filing → |